← All Clene INC filings

Clene INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
CLNN
Clene INC
Form 4: Clene Director Receives Stock Grant
Matthew Kiernan, a Director of Clene Inc., received 3,195 shares of common stock on August 13, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Receives Stock Grant
Arjun Jj Desai, a Director of Clene Inc., received 3,674 shares of common stock on August 13, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Receives Stock Grant
Alison Mosca, a Director of Clene Inc., received 4,872 shares of common stock on August 13, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Receives Stock Grant
David J Matlin, a Director of Clene Inc., received 6,230 shares of common stock on August 13, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Receives Stock Grant
Shalom Jacobovitz, a Director of Clene Inc., received 4,752 shares of common stock on August 13, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Receives Stock Grant
Jonathon Gay, a Director of Clene Inc., received 3,794 shares of common stock on August 13, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Receives Stock Grant
Vallerie Mclaughlin, a Director of Clene Inc., received 3,514 shares of common stock on August 13, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Receives Stock Grant
Reed N Wilcox, a Director of Clene Inc., received 3,514 shares of common stock on August 13, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Insider Reports Stock Transaction
Chidozie Ugwumba, a 10% owner of Clene Inc., reported multiple transactions in common stock on July 17, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Insider Reports Stock Option Grant
Clene Inc. Chief Science Officer Mark Mortenson received a stock option grant for 45,000 shares.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Executive Granted Stock Options
Clene Inc. reports the grant of 65,000 stock options to President & CEO Robert Etherington.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Executive Reports Stock Option Grant
Clene Inc. Chief Financial Officer Morgan R. Brown reports the grant of 15,000 stock options with an exercise price of $5.53.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Receives Stock Option Grant
Director Vallerie McLaughlin was granted stock options for 3,564 shares of Clene Inc. common stock on May 21, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Arjun Desai Receives Stock Options
Director Arjun Desai was granted 3,658 stock options in Clene Inc. as part of the company's 2020 Stock Plan.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Alison Mosca Receives Stock Options
Director Alison Mosca was granted 4,361 stock options in Clene Inc. as part of the company's 2020 Stock Plan.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Receives Stock Option Grant
Director David J. Matlin was granted stock options for 5,159 shares of Clene Inc. common stock on May 21, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Shalom Jacobovitz Receives Stock Options
Director Shalom Jacobovitz was granted 4,291 stock options in Clene Inc. as part of the company's 2020 Stock Plan.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Matthew Kiernan Receives Stock Options
Director Matthew Kiernan was granted 3,376 stock options in Clene Inc. as part of the company's 2020 Stock Plan.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Receives Stock Option Grant
Director Jonathon Gay was granted stock options for 3,728 shares of Clene Inc. common stock on May 21, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Receives Stock Option Grant
Director Reed N. Wilcox was granted stock options for 3,564 shares of Clene Inc. common stock on May 21, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Chidozie Ugwumba Sells Clene Inc. Stake, Exits Reporting
Reporting person Chidozie Ugwumba has sold a significant portion of his stake in Clene Inc., falling below the 10% ownership threshold.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Insider Sells 78,679 Shares
Reporting person Chidozie Ugwumba sold a total of 78,679 shares of Clene Inc. common stock held by SymBiosis II, LLC.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Insider Sells Shares via SymBiosis II, LLC
Reporting person Chidozie Ugwumba sold a total of 19,497 shares of Clene Inc. common stock across three transactions in late April 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Insider Sells 65,663 Shares
Reporting person Chidozie Ugwumba sold 65,663 shares of Clene Inc. common stock held by SymBiosis II, LLC across two transactions.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Insider Divests Shares via SymBiosis II, LLC
Reporting person Chidozie Ugwumba sold a total of 39,162 shares of Clene Inc. common stock across three transactions in April 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Reports Stock Transaction
Clene Inc. director Ugwumba Chidozie reported a transaction involving the acquisition of 24,925 shares of common stock at $4.81 per share.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Sells Shares in Pre-Planned Transaction
Clene Inc. Director Chidozie Ugwumba reported a pre-planned sale of 4,278 common shares at $4.97 per share, effective April 1, 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Inc. Director Sells Over 100K Shares
Clene Inc. director and 10% owner, Chidozie Ugwumba, reported selling 100,997 shares of common stock through SymBiosis II, LLC in late March 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Sells 17,909 Shares in Discretionary Trades
Clene Inc. Director and 10% owner Chidozie Ugwumba reported multiple discretionary sales of common stock totaling 17,909 shares in late March 2026.
NASDAQ
CLNN
Clene INC
Form 4: Clene Director Sells 5,559 Shares at $4.10
A Clene Inc. director and 10% owner, Chidozie Ugwumba, reported the sale of 5,559 shares of common stock.